RxDoctor Payments Data

Daniel Herman, MD

Anatomic Pathology & Clinical Pathology · Philadelphia, PANPI 1063855344

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,643 of the $9,993 with a category attached, or 66.5%. Roche Diagnostics Corporation accounts for 66.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $6,643 and has fallen 75.9% since, to $1,600 in 2023. Among anatomic pathology & clinical pathology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,993in general payments, 2019–2025

Across 5 payments — averaging $1998.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$7K
  • Blueprint Medicines Corporation$2K
  • Abbott$2K
$980,577in research payments, 2019–2025

Across 2 payments — averaging $490,289 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Blueprint Medicines Corporation$981K

What the payments were for

  • Speaking & faculty fees$3,26033%
  • Travel & lodging$6,64366%
  • Education$911%

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,993 in reported general payments places this provider in the 95th percentile of 357 anatomic pathology & clinical pathology providers in Pennsylvania.

See all anatomic pathology & clinical pathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$55,992
Medicare patients
1,516
Services billed
3,181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →